November 25, 2020 6 p.m. - 7 p.m.
Join us for this important webinar on mental health presented by Nikki Callan from the Metagenics Clinical Education team.
Anxiety and depression are highly prevalent conditions being the top two causes of disability worldwide. The impact of COVID-19 this year alone has seen these rates soar, and along with it anxiolytic and antidepressant prescriptions. In this webinar:
• Dispel the monoamine theory and reveal the root causes that promote mood disorders.• Discover the drivers that lead to changes in brain architecture present in anxiety and depression.• Learn the role of oral therapeutics and exercise in enhancing neuroplasticity.• Understand the relationship between sleep disturbances and insomnia and their role in mood disorders.• Ascertain how to implement changes to assist your patient.• Learn how to apply this knowledge and witness life changing results through case studies that focus on enhancing mood and improving sleep.
Nikki Callan (BHSc Nutrition, Adv Dip Nat), from the Metagenics Clinical Education team has experience working as a naturopath and within the complementary therapy industry both internationally and in Australia. Nikki gained clinical experience internationally working with patient’s afflicted by gut disorders, CIRS, chronic infections and addictions. Nikki has a love of biochemistry and a keen interest in detoxification, immune dysfunction, neuro-inflammatory and mental health disorders including addictions.